⌘K

Login Start Free

Home/Filings/4/0001209191-17-062223

4//SEC Filing

Motahari Saeed 4

Accession 0001209191-17-062223

CIK 0001516479other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 9:01 PM ET

Size

8.4 KB

Accession

0001209191-17-062223

Insider Transaction Report

Form 4

Period: 2017-11-17

Insys Therapeutics, Inc.INSY

DirectorPresident & CEO

Transactions

Award
Stock Option (right to buy)
2017-11-17+40,000→ 40,000 total
Exercise: $5.37Exp: 2027-11-16→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The option shall vest in 36 equal monthly installments until fully vested and exercisable on November 17, 2020.

Documents

2 files

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeother

Related Parties

1

filerCIK 0001704399

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 9:01 PM ET
Size: 8.4 KB

View on SEC.gov